Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus
CONCLUSION: The lower prevalence of MAFLD with coexisting significant fibrosis we observed in adults with T1DM using CSII therapy, compared to those using MDI therapy, is primarily mediated by inter-group differences in age.PMID:37708990 | DOI:10.1016/j.diabet.2023.101477
Source: Diabetes and Metabolism - Category: Endocrinology Authors: Alessandro Csermely Alessandro Mantovani Mario Luca Morieri Luisa Palmisano Maria Masulli Efisio Cossu Marco Giorgio Baroni Katia Bonomo Flavia Agata Cimini Gisella Cavallo Raffaella Buzzetti Carmen Mignogna Frida Leonetti Simonetta Bacci Roberto Trevisan Source Type: research
More News: Diabetes | Diabetes Mellitus | Diabetes Type 1 | Endocrinology | Fatty Liver Disease (FLD) | Insulin | Liver | Liver Disease | Study | Urology & Nephrology